FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer
February 14, 2018 – Today the U.S. Food and Drug Administration (FDA) approved apalutamide (Erleada, also previously called ARN-509) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC). This...Read More
Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces Milestone in Accelerating Development of Liquid Biopsy for Cancer: Initial Release of Open Data
CHICAGO – Exactly one year after its establishment as an independent non-profit, The Blood Profiling Atlas in Cancer Consortium (BloodPAC) announced the public release and accessibility of an initial dataset....Read More
Two new treatments have been found for prostate cancer patients who previously had no effective treatment options
Over the course of prostate cancer progression, there can come a time during which the cancer is progressing, but there are no treatments known to improve survival. One of these...Read More
FDA approves Abiraterone + Prednisone for Earlier Treatment of Metastatic Prostate Cancer
Back in June, we told you about the early results of the LATITUDE clinical trial, presented at the 2017 ASCO conference. The study indicated that giving abiraterone in combination with...Read More
Statins and Prostate Cancer: The Search for the Magic Bullet
Do statins lower your risk of getting aggressive prostate cancer? Well, they may. Study after study hints at a tantalizing connection between taking these cholesterol-lowering drugs and protection from getting...Read More
The Prostate Cancer Foundation Honors Family And Caregivers During February With The True Love Contest
SANTA MONICA, CA, January 31, 2018 – Starting February 1st, the Prostate Cancer Foundation (PCF) will kick-off a month-long TRUE Love contest that honors family and caregivers for their tireless...Read More
The Prostate Cancer Foundation Awards Unprecedented Number of New Research Grants
SANTA MONICA, Calif., January 23, 2018 – Celebrating its 25th year as the global leader in driving cutting-edge research leading to treatments and cures for prostate cancer, the Prostate Cancer...Read More
Cleveland Clinic researchers find new gene variant linked to deadly prostate cancer
Jan. 17 2018, Cleveland: Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer. The research, led by Nima...Read More
$2.5 Million Gift from Robert Frederick Smith to the Prostate Cancer Foundation is the Largest Donation Ever Dedicated to Advancing Prostate Cancer Research in African-American Men
SANTA MONICA, CA Jan. 14, 2018 – Helping to advance revolutionary research in prostate cancer, Robert F. Smith, Founder, Chairman and CEO of Vista Equity Partners, has donated $2.5 million...Read More
Star-Studded Album Honoring Dan Fogelberg Will Benefit the Prostate Cancer Foundation
LOS ANGELES, November 21, 2017 - The highly-anticipated album, A Tribute to Dan Fogelberg, is now available on CD, digital and streaming platforms. Released worldwide through BMG, sales will benefit the Prostate...Read More